Preparation of a porous artificial bone composite of silk fibroin hydroxyapatite and hyaluronic acid
By preparing silk fibroin/hyaluronic acid composite powder and depositing hydroxyapatite using in-situ precipitation, combined with modified hyaluronic acid and slow-release hydroxyapatite, the mechanical properties and degradation problems of existing material systems were solved, and a porous artificial bone with excellent mechanical properties and bone regeneration ability was prepared, which is suitable for industrial production.
Patent Information
- Application Number
- CN202411269888.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-11
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-09-11
AI Technical Summary
Existing biphase composite systems of hyaluronic acid and hydroxyapatite, and silk fibroin and hydroxyapatite, suffer from problems such as rapid degradation of hyaluronic acid, difficulty in maintaining stable dispersion of hydroxyapatite due to the low viscosity of silk fibroin solution over a long period of time, and difficulty in achieving uniform mixing of the three phases, resulting in insufficient mechanical properties and bone regeneration capacity.
By preparing silk fibroin/hyaluronic acid composite powder, depositing hydroxyapatite using in-situ precipitation, and combining modified hyaluronic acid and slow-release hydroxyapatite, the ratio of hyaluronic acid to silk fibroin solution was controlled to prepare porous artificial bone with excellent mechanical properties and controllable degradation properties.
It achieves mechanical stability and biocompatibility of porous artificial bone, provides excellent mechanical properties and bone regeneration capacity, promotes the repair and healing of bone defects, and is suitable for mass industrial production.
Smart Images

Figure CN118767212B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of medical biomaterials, and specifically discloses the preparation of a silk fibroin hydroxyapatite hyaluronic acid composite porous artificial bone. Background Art
[0002] Bone is a connective tissue that protects internal organs and provides support for the body. With the increasing trend of aging worldwide, bone damage or bone defects caused by congenital defects, degenerative diseases, traumatic injuries or surgical removal of tumors not only bring physical pain to people, but also affect daily life and actions, and may even lead to deformity and death. Although bone tissue has a certain ability to repair and regenerate itself, severe bone defects cannot heal on their own and still require clinical intervention. In clinical practice, the standard treatment for severe bone defects is usually autologous bone transplantation and allogeneic bone transplantation. However, autologous bone transplantation has limited sources and causes additional morbidity related to donor site healing. Allogeneic bone transplantation also has the risk of disease transmission and immune rejection. These risks associated with bone transplantation are particularly serious in the elderly. In recent years, with the development of science and technology, bone tissue engineering has provided a new research strategy for promoting the repair and regeneration of bone defect sites. Among them, tissue engineering scaffolds are biological carriers on which seed cells survive before forming tissues, which can provide a place for physiological activities such as cell adhesion, proliferation, differentiation, metabolism and tissue regeneration.
[0003] Ideal artificial bone scaffold materials should simulate the composition and structure of natural extracellular matrix. The combination of protein and polysaccharide has attracted wide attention because of its similar composition to extracellular matrix, good biocompatibility and positive effect on tissue regeneration and repair process. As a natural protein material, silk fibroin has good biocompatibility, adjustable biodegradability, low immunogenicity and abundant raw material supply, and has been used in the field of bone repair. Hyaluronic acid is a kind of high molecular weight polysaccharide widely present in animals and microorganisms, and is also a natural component of extracellular matrix. It can be used for the preparation of tissue engineering materials because of its lack of species difference, immunogenicity and good biosafety. In addition, the main component of inorganic phase in natural bone tissue is hydroxyapatite, which can realize chemical bond with body tissue at the interface, has a certain solubility in the body, can release ions that are harmless to the body, participates in metabolism in the body, has a stimulating or inducing effect on bone hyperplasia, and promotes the repair of bone defect tissue. It is a common raw material for registered and sold artificial bone materials.
[0004] The currently common two-phase composite material systems of hyaluronic acid and hydroxyapatite, and silk fibroin and hydroxyapatite have some problems, such as the rapid degradation of hyaluronic acid, which cannot support the mechanical and bone regeneration capacity required for bone defects for a long time; the low viscosity of silk fibroin solution makes it difficult to fix the stable dispersion of hydroxyapatite for a long time, and the three-phase mixed system has the problem of being difficult to mix evenly; therefore, it is of great significance to study a composite porous artificial bone with excellent mechanical properties and usage effects. Summary of the invention
[0005] The purpose of the present invention is to provide a method for preparing a silk fibroin hydroxyapatite hyaluronic acid composite porous artificial bone to solve the problems raised in the above background technology.
[0006] In order to solve the above technical problems, the present invention provides the following technical solutions: A preparation method of a silk fibroin hydroxyapatite hyaluronic acid composite porous artificial bone, comprising the following steps: S1: (1) taking degummed silk, dissolving it with a lithium bromide solution, dialyzing, filtering, and centrifuging to obtain a silk fibroin solution with a concentration of 3-6wt%; (2) preparing a hyaluronic acid solution with a concentration of 1-5wt%;
[0007] S2: Mix a silk fibroin solution and a hyaluronic acid solution in a mass ratio of (6-7):(4-5), add diglycidyl ether (1,4-butanediol diglycidyl ether), mix evenly, freeze, freeze-dry, absorb moisture at room temperature, crush, and sieve to obtain a silk fibroin / hyaluronic acid composite powder;
[0008] S3: Take diglycidyl ether, sodium hydroxide solution (1 mol / L sodium hydroxide aqueous solution), hyaluronic acid solution, and silk fibroin / hyaluronic acid composite powder, mix them evenly, gradually add calcium chloride solution (1 wt% calcium chloride aqueous solution) while stirring, mix evenly, add phosphorus ion solution, mix evenly, pour into a mold, and post-treat to obtain a composite porous artificial bone.
[0009] Preferably, the centrifugation conditions are: 4°C, 8000-9000 rpm, and centrifugation for 20-25 minutes.
[0010] Preferably, in the silk fibroin solution, the volume ratio of the degummed silk to the lithium bromide solution is 1:4-1:10, the concentration of the lithium bromide solution is 9-10 mol / L, and the rest is water;
[0011] In step S2, the amount of diglycidyl ether added is 5-10% of the mass of the silk fibroin solution.
[0012] The composite porous artificial bone comprises the following raw materials, calculated by weight: 1-2 parts of diglycidyl ether, 1-2 parts of sodium hydroxide solution, 100-120 parts of hyaluronic acid solution, 8-12 parts of silk fibroin / hyaluronic acid composite powder, 1-2 parts of calcium chloride solution, and 30-40 parts of phosphorus ion solution.
[0013] Preferably, the hyaluronic acid solution comprises hyaluronic acid with a molecular weight of 100-240w.
[0014] Preferably, the hyaluronic acid solution further comprises modified hyaluronic acid and double-bonded hyaluronic acid.
[0015] Preferably, the hyaluronic acid solution includes a hyaluronic acid composition with a concentration of 1-5wt%, and the rest is water; the hyaluronic acid composition includes hyaluronic acid with a molecular weight of 100-240w, modified hyaluronic acid, and double-bonded hyaluronic acid;
[0016] The preparation of the double-bonded hyaluronic acid comprises the following steps: taking sodium hyaluronate and water, stirring evenly, adding methacrylic anhydride, reacting at 0°C for 20-24 hours, adjusting the pH value to 8-10 during the reaction, dialyzing, and freeze-drying to obtain the double-bonded hyaluronic acid;
[0017] The preparation of the modified hyaluronic acid comprises the following steps: taking hyaluronic acid, water-soluble collagen and water, stirring evenly, adding glutaraldehyde, stirring at 50-60° C. for 2-4 hours, dialyzing and freeze-drying to obtain the modified hyaluronic acid;
[0018] Among them, double-bonded hyaluronic acid, due to its double bonds, can participate in subsequent cross-linking reactions and improve the mechanical strength of hyaluronic acid; modified hyaluronic acid contains collagen, which promotes cell adhesion, has anti-inflammatory effects, and promotes bone repair.
[0019] Preferably, the mass ratio of the hyaluronic acid, modified hyaluronic acid and double-bonded hyaluronic acid is (1-2):1:(7-8).
[0020] Preferably, the double-bonded hyaluronic acid comprises the following raw materials, calculated by weight: 2-3 parts of sodium hyaluronate, 200 parts of water, and 3-4 parts of methacrylic anhydride;
[0021] The modified hyaluronic acid comprises the following raw materials, calculated by weight: 3-5 parts of hyaluronic acid, 2-3 parts of water-soluble collagen, 200 parts of water, and 3-5% of glutaraldehyde by weight of water.
[0022] Preferably, the phosphorus ion solution comprises 30-35 wt % hydroxyapatite and the rest is water.
[0023] Preferably, the phosphorus ion solution comprises 30-35 wt % of a hydroxyapatite composition, 0.005-0.008 g / mL of a photoinitiator, and the remainder is water; the hydroxyapatite composition comprises modified hydroxyapatite and slow-release hydroxyapatite in a mass ratio of (1-2):8;
[0024] The preparation of the sustained-release hydroxyapatite comprises the following steps: Step 1: taking hydroxyapatite and silver nitrate solution, mixing them evenly, standing them for 24 hours, filtering, washing, and drying them to obtain modified hydroxyapatite;
[0025] Step 2: Take hyaluronic acid solution and silk fibroin solution of different mass ratios in turn, mix them to obtain a mixed solution, add modified hydroxyapatite and glutaraldehyde, stir at 50-60°C for 1.5-2h, vacuum aspirate under negative pressure, centrifuge, and dry to obtain sustained-release hydroxyapatite.
[0026] Preferably, in the modified hydroxyapatite, the mass ratio of hydroxyapatite to silver nitrate (AgNO3) solution is 1:(10-12); in the sustained-release hydroxyapatite, the amount of modified hydroxyapatite added is 10-15% of the mass of the mixed solution; the amount of glutaraldehyde added is 8-12% of the mass of the modified hydroxyapatite;
[0027] The sustained-release hydroxyapatite includes sustained-release hydroxyapatite A, sustained-release hydroxyapatite B, and sustained-release hydroxyapatite C; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is (3-4):1, sustained-release hydroxyapatite A is obtained; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is (1-2):1, sustained-release hydroxyapatite B is obtained; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 1:(4-6), sustained-release hydroxyapatite C is obtained; the mass ratio of the sustained-release hydroxyapatite A, sustained-release hydroxyapatite B, and sustained-release hydroxyapatite C is 1:(1-2):(2-3);
[0028] After modification, hydroxyapatite is loaded with nanosilver, which has antibacterial and anti-inflammatory effects. By controlling the ratio of hyaluronic acid solution and silk fibroin solution, sustained-release hydroxyapatite is prepared to improve the use effect of composite porous artificial bone.
[0029] Preferably, the concentration of the silver nitrate solution is 10 -4 mol / L.
[0030] Preferably, the post-treatment comprises the following steps: irradiation under ultraviolet light with a wavelength of 360 nm for 0 to 8 min, an irradiation distance of 5 cm, freezing at -20 to -40°C overnight, and freeze drying for 48 to 50 h.
[0031] Preferably, during dialysis, a dialysis bag with a molecular weight cutoff of 14 kDa is used; the molecular weight has a great influence on the mechanical strength of the composite porous artificial bone, so dialysis is required.
[0032] Compared with the prior art, the beneficial effects achieved by the present invention are as follows: (1) Silk fibroin serves as the skeleton of the artificial bone scaffold, provides mechanical stability, and undergoes slow biodegradation; hyaluronic acid improves the dispersion stability of hydroxyapatite, and enhances the hydrophilicity and biological response of the scaffold; silk fibroin / hyaluronic acid composite powder is first prepared to avoid the precipitation of silk fibroin during solution mixing; hydroxyapatite is deposited by in-situ precipitation, and finally a porous artificial bone with excellent mechanical properties, controllable components and degradation properties is prepared; the operation is simple, the proportion of each component is easy to control, and large-scale industrial production can be achieved;
[0033] (2) Prepare sustained-release hydroxyapatite by first depositing nanosilver on its surface, which has the effect of promoting wound healing; by adjusting the addition ratio of hyaluronic acid solution and silk fibroin solution, prepare sustained-release hydroxyapatite A, sustained-release hydroxyapatite B, and sustained-release hydroxyapatite C, which have sustained-release properties and different release times. The higher the proportion of hyaluronic acid solution, the faster the release. By adjusting the addition amount of the three sustained-release hydroxyapatites, the step-by-step release of hydroxyapatite is controlled to match the bone regeneration rate and facilitate osteogenesis;
[0034] (3) Double-bonded hyaluronic acid was prepared to improve the problem of hyaluronic acid being easily degraded and having insufficient mechanical properties. The double bonds can also participate in the cross-linking reaction in the subsequent steps, further improving the mechanical strength of the resulting artificial bone. Water-soluble collagen was added to the modified hyaluronic acid. Collagen can regulate inflammatory responses and interact well with cells, thus promoting bone repair. It can be mixed with unmodified hyaluronic acid in a certain proportion to obtain an artificial bone with good mechanical properties and good bone repair promoting effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:
[0036] Figure 1 This is an electron microscope image of the composite porous artificial bone. DETAILED DESCRIPTION
[0037] The following is a preferred implementation of the embodiment of the present invention. Obviously, the described embodiment is only a part of the embodiment of the present invention, not all of the embodiments. For ordinary technicians in this technical field, all other embodiments obtained by ordinary technicians in this field without creative work without departing from the principle of the embodiment of the present invention are within the scope of protection of the present invention.
[0038] The following parts are by mass unless otherwise specified;
[0039] Preparation of silk fibroin solution: take degummed silk, dissolve it with 9.3 mol / L lithium bromide solution, the bath ratio of degummed silk to lithium bromide is 1:8, and the dissolution process is carried out at 60°C; cool it, put it into a dialysis bag with a molecular weight cutoff of 14 kDa, dialyze it with flowing purified water for three days, take it out, filter it through gauze, centrifuge it at 4°C and 9000 rpm for 20 minutes, and prepare a 5wt% silk fibroin solution;
[0040] Preparation of silk fibroin / hyaluronic acid composite powder: 60 parts of silk fibroin solution and 40 parts of hyaluronic acid solution were mixed, 8% of the mass of silk fibroin solution was added with 1,4-butanediol diglycidyl ether, mixed evenly, frozen at -80°C for 40 hours, freeze-dried in a freeze dryer, placed at room temperature for 3 days to absorb moisture, crushed into uniform powder by a grinder, and passed through a sieve with a pore size of 0.075 mm to obtain silk fibroin / hyaluronic acid composite powder;
[0041] Example 1: S1: preparing a hyaluronic acid solution (the hyaluronic acid concentration is 5 wt %, and the rest is water);
[0042] S2: Take 2 parts of 1,4-butanediol diglycidyl ether, 2 parts of sodium hydroxide solution, 100 parts of hyaluronic acid solution, and 10 parts of silk fibroin / hyaluronic acid composite powder, mix well, gradually add 1 part of calcium chloride solution while stirring, mix well, add 35 parts of phosphorus ion solution (30wt% hydroxyapatite, the rest is water), mix well, pour into a mold, and post-process (freeze in a -30℃ refrigerator overnight, freeze-dry for 48h) to obtain a composite porous artificial bone.
[0043] Example 2: S1: preparing a hyaluronic acid solution (the concentration of the hyaluronic acid composition is 5wt%, and the rest is water; the hyaluronic acid composition comprises hyaluronic acid, modified hyaluronic acid, and double-bonded hyaluronic acid in a mass ratio of 2:1:7);
[0044] Preparation of double-bonded hyaluronic acid: 3 parts of sodium hyaluronate and 200 parts of water were mixed evenly, 4 parts of methacrylic anhydride were added, and the mixture was reacted at 0°C for 24 hours. During the reaction, 1 mol / L sodium hydroxide solution was added dropwise to adjust the pH value to 9. The mixture was placed in a dialysis bag with a molecular weight cutoff of 14 kDa, and dialyzed with flowing purified water for 5 days. The mixture was taken out and freeze-dried to obtain double-bonded hyaluronic acid.
[0045] Preparation of modified hyaluronic acid: Take 5 parts of hyaluronic acid, 2 parts of water-soluble collagen, and 200 parts of water, stir evenly, add glutaraldehyde with a water mass ratio of 5%, stir at 60°C for 3 hours, put into a dialysis bag with a molecular weight cutoff of 14 kDa, dialyze with flowing purified water for 5 days, take out, and freeze-dry to obtain modified hyaluronic acid;
[0046] S2: Take hydroxyapatite and 10 times its mass of 10 -4 mol / L AgNO3 solution, mix well, let stand for 24 hours, filter, wash, and dry to obtain modified hydroxyapatite;
[0047] The hyaluronic acid solution and the silk fibroin solution of different mass ratios were sequentially taken and mixed to obtain a mixed solution; 15% of the mass of the mixed solution of modified hydroxyapatite was added to the mixed solution, and 12% of the mass of the modified hydroxyapatite of glutaraldehyde was added, and the mixture was stirred at 60°C for 2h, and vacuum-sucked at a negative pressure of 0.1Mpa until no obvious bubbles were seen around the modified hydroxyapatite, and the mixture was taken out, centrifuged at a speed of 1000r / min for 10min, and dried to obtain sustained-release hydroxyapatite in sequence;
[0048] The sustained-release hydroxyapatite includes sustained-release hydroxyapatite A, sustained-release hydroxyapatite B, and sustained-release hydroxyapatite C. When the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 4:1, sustained-release hydroxyapatite A is obtained; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 1:1, sustained-release hydroxyapatite B is obtained; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 1:5, sustained-release hydroxyapatite C is obtained;
[0049] S3: Take 2 parts of 1,4-butanediol diglycidyl ether, 2 parts of 1 mol / L sodium hydroxide solution, 100 parts of hyaluronic acid solution, and 10 parts of silk fibroin / hyaluronic acid composite powder, mix well, gradually add 1 part of calcium chloride solution while stirring, mix well, add 35 parts of phosphorus ion solution (30wt% hydroxyapatite composition, photoinitiator phenyl (2,4,6-trimethylbenzoyl) lithium phosphate with a concentration of 0.005g / mL, and the rest is water; the hydroxyapatite composition includes modified hydroxyapatite and sustained-release hydroxyapatite in a mass ratio of 2:8; wherein the mass ratio of sustained-release hydroxyapatite A, sustained-release hydroxyapatite B, and sustained-release hydroxyapatite C is 1:1:2.5), mix well, pour into a mold, and post-treat (irradiate with light at a wavelength of 360nm for 8min, the illumination distance is 5cm, place in a -40℃ refrigerator and freeze overnight, and freeze-dry for 48h) to obtain a composite porous artificial bone.
[0050] Example 3: S1: preparing a hyaluronic acid solution (the concentration of the hyaluronic acid composition is 5wt%, and the rest is water; the hyaluronic acid composition comprises hyaluronic acid, modified hyaluronic acid, and double-bonded hyaluronic acid in a mass ratio of 2:1:8);
[0051] Preparation of double-bonded hyaluronic acid: 3 parts of sodium hyaluronate and 200 parts of water were mixed evenly, 4 parts of methacrylic anhydride were added, and the mixture was reacted at 0°C for 24 hours. During the reaction, 1 mol / L sodium hydroxide solution was added dropwise to adjust the pH value to 9. The mixture was placed in a dialysis bag with a molecular weight cutoff of 14 kDa, and dialyzed with flowing purified water for 5 days. The mixture was taken out and freeze-dried to obtain double-bonded hyaluronic acid.
[0052] Preparation of modified hyaluronic acid: Take 5 parts of hyaluronic acid, 2 parts of water-soluble collagen, and 200 parts of water, stir evenly, add glutaraldehyde with a water mass ratio of 5%, stir at 60°C for 3 hours, put into a dialysis bag with a molecular weight cutoff of 14 kDa, dialyze with flowing purified water for 5 days, take out, and freeze-dry to obtain modified hyaluronic acid;
[0053] S2: Take hydroxyapatite and 10 times its mass of 10 -4 mol / L AgNO3 solution, mix well, let stand for 24 hours, filter, wash, and dry to obtain modified hydroxyapatite;
[0054] The hyaluronic acid solution and the silk fibroin solution of different mass ratios were sequentially taken and mixed to obtain a mixed solution; 15% of the mass of the mixed solution of modified hydroxyapatite was added to the mixed solution, and 12% of the mass of the modified hydroxyapatite of glutaraldehyde was added, and the mixture was stirred at 60°C for 2h, and vacuum-sucked at a negative pressure of 0.1Mpa until no obvious bubbles were seen around the modified hydroxyapatite, and the mixture was taken out, centrifuged at a speed of 1000r / min for 10min, and dried to obtain sustained-release hydroxyapatite in sequence;
[0055] The sustained-release hydroxyapatite includes sustained-release hydroxyapatite A, sustained-release hydroxyapatite B, and sustained-release hydroxyapatite C. When the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 3:1, sustained-release hydroxyapatite A is obtained; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 2:1, sustained-release hydroxyapatite B is obtained; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 1:6, sustained-release hydroxyapatite C is obtained;
[0056] S3: Take 2 parts of 1,4-butanediol diglycidyl ether, 2 parts of 1 mol / L sodium hydroxide solution, 100 parts of hyaluronic acid solution, and 10 parts of silk fibroin / hyaluronic acid composite powder, mix well, gradually add 1 part of calcium chloride solution while stirring, mix well, add 35 parts of phosphorus ion solution (30wt% hydroxyapatite composition, photoinitiator phenyl (2,4,6-trimethylbenzoyl) lithium phosphate with a concentration of 0.005g / mL, and the rest is water; the hydroxyapatite composition includes modified hydroxyapatite and sustained-release hydroxyapatite in a mass ratio of 2:8; wherein the mass ratio of sustained-release hydroxyapatite A, sustained-release hydroxyapatite B, and sustained-release hydroxyapatite C is 1:2:3), mix well, pour into a mold, and post-treat (irradiate with light at a wavelength of 360nm for 8min, the illumination distance is 5cm, place in a -40℃ refrigerator and freeze overnight, and freeze-dry for 48h) to obtain a composite porous artificial bone.
[0057] Comparative Example 1 (changing the amount of each raw material added in the hydroxyapatite composition, and the other method steps are consistent with Example 2): The hydroxyapatite composition includes modified hydroxyapatite and sustained-release hydroxyapatite in a mass ratio of 3:8; wherein the mass ratio of sustained-release hydroxyapatite A, sustained-release hydroxyapatite B, and sustained-release hydroxyapatite C is 2:1:1.
[0058] Comparative Example 2 (when preparing silk fibroin / hyaluronic acid composite powder, the ratio of silk fibroin solution to hyaluronic acid solution is changed, and the other method steps are consistent with Example 2): 40 parts of silk fibroin solution and 60 parts of hyaluronic acid solution are mixed, 8% of the mass of silk fibroin solution 1,4-butanediol diglycidyl ether is added, mixed evenly, frozen at -80°C for 40 hours, freeze-dried in a freeze dryer, placed at room temperature to absorb moisture for 3 days, crushed into a uniform powder with a grinder, and passed through a sieve with a pore size of 0.075 mm to obtain a silk fibroin / hyaluronic acid composite powder.
[0059] Comparative Example 3 (changing the ratio of each raw material in the hyaluronic acid composition, and the other method steps are consistent with Example 2): prepare a hyaluronic acid solution (the concentration of the hyaluronic acid composition is 5wt%, and the rest is water; the hyaluronic acid composition includes hyaluronic acid, modified hyaluronic acid, and double-bonded hyaluronic acid in a mass ratio of 5:1:4).
[0060] Comparative Example 4 (the preparation process of sustained-release hydroxyapatite was changed, and the remaining steps were consistent with Example 2): hyaluronic acid solution and silk fibroin solution of different mass ratios were taken in sequence, mixed to obtain a mixed solution; hydroxyapatite of 15% by mass of the mixed solution was added to the mixed solution, glutaraldehyde of 25% by mass of the hydroxyapatite was added, stirred at 60° C. for 2 h, vacuum-sucked at a negative pressure of 0.1 MPa until no obvious bubbles were seen around the modified hydroxyapatite, taken out, centrifuged at a speed of 1000 r / min for 10 min, and dried to obtain sustained-release hydroxyapatite in sequence;
[0061] The sustained-release hydroxyapatite includes sustained-release hydroxyapatite A, sustained-release hydroxyapatite B and sustained-release hydroxyapatite C. When the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 4:1, sustained-release hydroxyapatite A is obtained; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 1:1, sustained-release hydroxyapatite B is obtained; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 1:5, sustained-release hydroxyapatite C is obtained.
[0062] In the above embodiments, the test methods used are conventional methods unless otherwise specified; the raw materials used are commercially available unless otherwise specified, and the sources of the raw materials are as follows: degummed silk (SF001, Suzhou Simet Biotechnology Co., Ltd.); lithium bromide (CAS: 7550-35-8); hyaluronic acid (molecular weight 120w, Shandong Haizhou Bioengineering Co., Ltd.); sodium hyaluronate (S12034, Shanghai Yuanye); methacrylic anhydride (CAS: 760-93-0); water-soluble collagen (S12007, Shanghai Yuanye); glutaraldehyde (CAS: 111-30-8); hydroxyapatite (S14126, Shanghai Yuanye); 1,4-butanediol diglycidyl ether (CAS: 2425-79-8); calcium chloride (S24110, Shanghai Yuanye); phenyl (2,4,6-trimethylbenzoyl) lithium phosphate (Y43995, Shanghai Yuanye).
[0063] Experiment: (1) The composite porous artificial bones prepared in Examples 1-3 and Comparative Examples 1-4 were solidified in a cylindrical mold with a diameter of 6 mm and a height of 5 mm, and the compressive strength was tested using a universal testing machine, with a 5000N indenter and a compression speed of 2 mm / min; (2) 35 adult white rabbits were taken and divided into 7 groups on average. A circular defect area with a diameter of 1.5 cm was artificially created on the top of the rabbit's skull. The composite porous artificial bones prepared in Examples 1-3 and Comparative Examples 1-4 were respectively ground into thin slices with a diameter of about 1.5 cm, implanted, and the periosteum and skin were sutured. After 28 weeks, the operation was performed again to observe the healing condition; the specific data are shown in the table below;
[0064]
[0065] Conclusion: In comparative example 1, the amount of each raw material added in the hydroxyapatite composition was changed, and the bone was not completely healed after 28 weeks, which shows the importance of the amount of each component added in the hydroxyapatite composition; in comparative example 2, when preparing the silk fibroin / hyaluronic acid composite powder, the ratio of silk fibroin solution to hyaluronic acid solution was changed. Due to the reduction of silk fibroin, the mechanical properties decreased, and due to the change in degradation rate and the dispersibility of hydroxyapatite, the bone injury was not completely healed; in comparative example 3, the ratio of each raw material in the hyaluronic acid composition was changed, and the compression strength and healing conditions were not as good as those in the embodiment, which shows the importance of the addition ratio; in comparative example 4, the preparation process of sustained-release hydroxyapatite was changed, the hydroxyapatite was not modified, and the amount of glutaraldehyde was increased, and the performance decreased; in summary, the silk fibroin hydroxyapatite hyaluronic acid composite porous artificial bone prepared by the present invention has good mechanical strength and is conducive to the healing of bone injuries.
[0066] Finally, it should be noted that the above is only a preferred embodiment of the present invention, but the protection scope of this application is not limited thereto. Any changes or substitutions that can be easily thought of by any technician familiar with the technical field within the spirit and principle of the present invention and within the technical scope disclosed in this application should be included in the protection scope of this application; in the absence of conflict, the embodiments of this application and the features in the embodiments can be combined with each other. Therefore, the protection scope of this application shall be based on the protection scope of the claims.
Claims
1. A preparation method of a silk fibroin hydroxyapatite hyaluronic acid composite porous artificial bone, characterized in that: The method comprises the following steps: S1: (1) taking degummed silk, dissolving it with lithium bromide solution, dialyzing, filtering and centrifuging to obtain a silk fibroin solution with a concentration of 3 to 6 wt%; (2) preparing a hyaluronic acid solution with a concentration of 1 to 5 wt%; S2: Mix a silk fibroin solution and a hyaluronic acid solution in a mass ratio of (6-7):(4-5), add diglycidyl ether, mix well, freeze, freeze-dry, absorb moisture at room temperature, crush, and sieve to obtain a silk fibroin / hyaluronic acid composite powder; S3: Take diglycidyl ether, sodium hydroxide solution, hyaluronic acid solution, and silk fibroin / hyaluronic acid composite powder, mix them evenly, gradually add calcium chloride solution while stirring, mix evenly, add phosphorus ion solution, mix evenly, pour into a mold, and post-treat to obtain a composite porous artificial bone; The hyaluronic acid solution comprises hyaluronic acid, modified hyaluronic acid and double-bonded hyaluronic acid with a molecular weight of 100 to 240w; the mass ratio of hyaluronic acid, modified hyaluronic acid and double-bonded hyaluronic acid is (1 to 2):1:(7 to 8); The preparation of the modified hyaluronic acid comprises the following steps: taking hyaluronic acid, water-soluble collagen and water, stirring evenly, adding glutaraldehyde, stirring at 50-60° C. for 2-4 hours, dialyzing and freeze-drying to obtain the modified hyaluronic acid; The preparation of the double-bonded hyaluronic acid comprises the following steps: taking sodium hyaluronate and water, stirring evenly, adding methacrylic anhydride, adjusting the pH value to 8-10, reacting at 0°C for 20-24h, dialyzing, and freeze-drying to obtain the double-bonded hyaluronic acid; The phosphorus ion-containing solution comprises 30-35 wt % of a hydroxyapatite composition, 0.005-0.008 g / mL of a photoinitiator, and the remainder is water; the hydroxyapatite composition comprises modified hydroxyapatite and slow-release hydroxyapatite in a mass ratio of (1-2):8; The preparation of the modified hydroxyapatite comprises the following steps: taking hydroxyapatite and silver nitrate solution, mixing them evenly, standing, filtering, washing, and drying to obtain modified hydroxyapatite; wherein the mass ratio of hydroxyapatite to silver nitrate solution is 1:(10-12); The preparation of the sustained-release hydroxyapatite comprises the following steps: taking hyaluronic acid solution and silk fibroin solution of different mass ratios in sequence, mixing to obtain a mixed solution, adding modified hydroxyapatite and glutaraldehyde, stirring at 50-60° C. for 1.5-2 hours, vacuuming under negative pressure, centrifuging, and drying to obtain sustained-release hydroxyapatite; The sustained-release hydroxyapatite comprises sustained-release hydroxyapatite A, sustained-release hydroxyapatite B, and sustained-release hydroxyapatite C in a mass ratio of 1:(1-2):(2-3); When the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is (3-4):1, the sustained-release hydroxyapatite A is obtained; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is (1-2):1, the sustained-release hydroxyapatite B is obtained; when the mass ratio of the hyaluronic acid solution to the silk fibroin solution in the mixed solution is 1:(4-6), the sustained-release hydroxyapatite C is obtained; The added amount of the modified hydroxyapatite is 10-15% of the mass of the mixed solution; and the added amount of glutaraldehyde is 8-12% of the mass of the modified hydroxyapatite.
2. The preparation method of a silk fibroin hydroxyapatite hyaluronic acid composite porous artificial bone according to claim 1, characterized in that: In the silk fibroin solution, the volume ratio of the degummed silk to the lithium bromide solution is 1:4-1:10, and the concentration of the lithium bromide solution is 9-10 mol / L; The composite porous artificial bone comprises the following raw materials, calculated by mass: 1-2 parts of diglycidyl ether, 1-2 parts of sodium hydroxide solution, 100-120 parts of hyaluronic acid solution, 8-12 parts of silk fibroin / hyaluronic acid composite powder, 1-2 parts of calcium chloride solution, and 30-40 parts of phosphorus ion solution.
3. The preparation method of a silk fibroin hydroxyapatite hyaluronic acid composite porous artificial bone according to claim 1, characterized in that: The modified hyaluronic acid comprises the following raw materials, calculated by weight: 3 to 5 parts of hyaluronic acid, 2 to 3 parts of water-soluble collagen, and 200 parts of water; the weight of the glutaraldehyde is 3 to 5% of the water; The double-bonded hyaluronic acid comprises the following raw materials, calculated by weight: 2 to 3 parts of sodium hyaluronate, 200 parts of water, and 3 to 4 parts of methacrylic anhydride.
4. The preparation method of a silk fibroin hydroxyapatite hyaluronic acid composite porous artificial bone according to claim 1, characterized in that: The post-treatment comprises the following steps in sequence: irradiation under ultraviolet light for 0 to 8 minutes, the irradiation distance is 5 cm, freezing at -20 to -40°C overnight, and freeze drying for 48 to 50 hours.
Citation Information
Patent Citations
Preparation method of hydroxyapatite-fibroin-titanium dioxide biological material
CN108498861A
Preparation method of composite bone tissue engineering stent material
CN109758609A
Preparation method of selenium-doped hydroxyapatite solution for 3D printing, artificial bone and artificial periosteum
CN114681676A
